Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain

Wenrui Huang, Jingsheng Liang, Chen Ching Yuan, Katarzyna Kazmierczak, Zhiqun Zhou, Ana Morales, Kim L. McBride, Sara M. Fitzgerald-Butt, Ray E. Hershberger, Danuta Szczesna-Cordary

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Dilated cardiomyopathy (DCM) is a disease of the myocardium characterized by left ventricular dilatation and diminished contractile function. Here we describe a novel DCM mutation in the myosin regulatory light chain (RLC), in which aspartic acid at position 94 is replaced by alanine (D94A). The mutation was identified by exome sequencing of three adult first-degree relatives who met formal criteria for idiopathic DCM. To obtain insight into the functional significance of this pathogenic MYL2 variant, we cloned and purified the human ventricular RLC wild-type (WT) and D94A mutant proteins, and performed in vitro experiments using RLC-mutant or WT-reconstituted porcine cardiac preparations. The mutation induced a reduction in the α-helical content of the RLC, and imposed intra-molecular rearrangements. The phosphorylation of RLC by Ca2+/calmodulin-activated myosin light chain kinase was not affected by D94A. The mutation was seen to impair binding of RLC to the myosin heavy chain, and its incorporation into RLC-depleted porcine myosin. The actin-activated ATPase activity of mutant-reconstituted porcine cardiac myosin was significantly higher compared with ATPase of wild-type. No changes in the myofibrillar ATPase-pCa relationship were observed in wild-type- or D94A-reconstituted preparations. Measurements of contractile force showed a slightly reduced maximal tension per cross-section of muscle, with no change in the calcium sensitivity of force in D94A-reconstituted skinned porcine papillary muscle strips compared with wild-type. Our data indicate that subtle structural rearrangements in the RLC molecule, followed by its impaired interaction with the myosin heavy chain, may trigger functional abnormalities contributing to the DCM phenotype. A novel myosin RLC mutation was identified, for the first time, to cause dilated cardiomyopathy in humans. Substitution of Alanine for Aspartic Acid at position 94 of the RLC was found to trigger subtle changes in the secondary structure of the RLC and alterations of RLC-MHC interactions. Mutation-elicited molecular changes in myosin-based chemo-mechanical coupling contribute to the D94A-dependent DCM phenotype.

Original languageEnglish (US)
Pages (from-to)2379-2393
Number of pages15
JournalFEBS Journal
Issue number12
StatePublished - Jun 1 2015


  • ATPase activity
  • RLC-reconstituted β-myosin
  • muscle contraction
  • phosphorylation
  • secondary structure

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain'. Together they form a unique fingerprint.

Cite this